Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Caribou Biosciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
CRBU
Nasdaq
8731
https://www.cariboubio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Caribou Biosciences Inc
Caribou Biosciences to Present Initial Dose Expansion Data from CB-010 ANTLER Phase 1 Trial in r/r B-NHL at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting
- Apr 24th, 2024 2:00 pm
Caribou Biosciences Announces Oral Presentation on In Vivo Cas12a chRDNA Genome Editing at the 27th Annual Meeting of the American Society of Gene and Cell Therapy (ASGCT)
- Apr 15th, 2024 1:00 pm
Caribou Biosciences Expands Clinical Development of CB-010 with FDA Clearance of IND in Lupus
- Apr 4th, 2024 8:00 pm
With 65% institutional ownership, Caribou Biosciences, Inc. (NASDAQ:CRBU) is a favorite amongst the big guns
- Apr 1st, 2024 10:18 am
All You Need to Know About Caribou Biosciences, Inc. (CRBU) Rating Upgrade to Buy
- Mar 14th, 2024 4:00 pm
11 Oversold NASDAQ Stocks To Buy Right Now
- Mar 13th, 2024 7:32 pm
Why Caribou Biosciences Stock Is Crashing Today
- Mar 12th, 2024 4:37 pm
Caribou Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Mar 11th, 2024 8:05 pm
Caribou Biosciences to Present Preclinical Data on CB-012, an Allogeneic Anti-CLL-1 CAR-T Cell Therapy, at the American Association for Cancer Research (AACR) Annual Meeting
- Mar 5th, 2024 9:30 pm
12 $10 Stocks That Will Triple
- Feb 26th, 2024 6:14 pm
Missed Out on CRISPR Therapeutics? My Best Gene-Editing Stock to Buy and Hold
- Feb 26th, 2024 11:45 am
Steven Cohen's Point72 Adds Caribou Biosciences Inc to Its Portfolio
- Feb 24th, 2024 4:25 am
Caribou Biosciences to Participate in Upcoming Investor Conferences
- Feb 15th, 2024 9:05 pm
2 Risky Gene-Editing Stocks to Buy in the New Bull Market if You Dare
- Feb 12th, 2024 1:30 pm
Caribou Biosciences (NASDAQ:CRBU) Is In A Good Position To Deliver On Growth Plans
- Feb 7th, 2024 1:06 pm
3 Biotech Stocks You Can Buy and Hold for the Next Decade
- Jan 15th, 2024 1:45 pm
Caribou Biosciences Appoints Tim Kelly as Chief Technology Officer and Highlights Multiple Clinical Catalysts Expected in 2024
- Jan 7th, 2024 4:00 pm
3 Gene-Editing Stocks With the Potential to Mint Millionaires
- Dec 13th, 2023 10:20 am
Caribou Biosciences Provides Regulatory Update on CB-010 Pivotal Plan with Phase 3 Trial Initiation Expected by YE 2024
- Dec 12th, 2023 9:02 pm
Caribou Biosciences, Inc. (CRBU) Upgraded to Buy: What Does It Mean for the Stock?
- Dec 8th, 2023 5:00 pm
Scroll